2023 Speakers View the 25+ expert speakers at the 12th Tumour Models London Summit 2023. Adam Drake Head of In Vivo Pharmacology Ichnos Science Anna Erkstam Chief Executive Officer BioReperia Christophe Boudesco Associate Research Director of Translational Research Exscientia Clive Roper Director, Roper Toxicology Consulting Limited, & Vice President ESTIV David Gomez Jimenez Scientist Alligator Bioscience Etienne De Braekeleer Senior Scientist AstraZeneca Fabien Garcon Senior Scientist AstraZeneca Francesca Barone Chief Scientific Officer Candel Therapeutics Gabriel van der Pluijm Head of Urology Research Laboratory Leiden University Medical Center Jianming Xu Director of Functional Pharmacology Center GemPharmatech Jonathan Hollick Managing Director and Head of Research Breakpoint Therapeutics Josh Caggiula VP of Client Relations LIDE Kader Thiam Senior Vice President Discovery - Preclinical Models & Services GenOway Kainat Khan Associate Director AstraZeneca Livija Deban Chief Scientific Officer Prokarium Louis Gall Senior Scientist AstraZeneca Louise Ramos Scientist Rakovina Therapeutics Marc van Dijk Chief Scientific Officer MiNK Therapeutics Michael Boice Senior Director, Scientific Engagement and Key Accounts Certis Oncology Nicholas Glanville Vice President - Research Prokarium Paula Costales Vigil Senior Scientist Artios Pharma Philipp Metzger Senior Director - Study and In Vivo Pharmacology Reaction Biology Rita Fior Group Leader Champalimaud Foundation Rose Ann Padua Director INSERM Sheri Barnes Head, Scientific Development, Preclinical Oncology LabCorp Sumit Kumar Senior Scientist AstraZeneca Tomasz Grabowski Head, Preclinical Development JJP Biologics 2023 EVENT GUIDE REGISTER INTEREST